

<h3>Bibliografía</h3>

    <ol>
        <li>Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P. Rare bleeding disorders. Haemophilia 2012;18(Suppl 4):148-53.</li>
        <li>Peyvandi F, Palla R, Menegatti M, Mannucci PM. Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management. Semin Thromb Hemost 2009;35(4):349-55.</li>
        <li>Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012;10:615:21.</li>
        <li>Acharya SS, Coughlin A, Dimichele DM. North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004;2:248-56.</li>
        <li>Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015;125(13):2052-61.</li>
        <li>Peyvandi F, Di Michele D, Bolton-Maggs PHB, Lee CA, Tripodi A, Srivastava A. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012;10:1938-43.</li>
        <li>Livnat T, Barg AA, Levy-Mendelovich S, Kenet G. Rare bleeding disorders-old diseases in the era of novel options for therapy. Blood Cells Mol Dis 2017;14:S1079-9796.</li>
        <li>Siboni S, Zanon E, Sottilotta G, Consonni D, Castaman G, Mikovic D, et al. Central nervous system bleeding in patients with rare bleeding disorders. Haemophilia 2012;18:34-8.</li>
        <li>Kadir R, Chi C, Bolton Maggs P. Pregnancy and rare bleeding disorders. Haemophilia 2009;15(5):990-1005.</li>
        <li>Muszbek L, Bagoly Z, Cairo A, Peyvandi F. Novel aspects of factor XIII deficiency. Curr Opin Hematol 2011;18(5):366-72.</li>
        <li>Lu JT, Campeau PM, Lee BH. Genotypephenotype correlation promiscuity in the era of next-generation sequencing. New Engl J Med 2014;371:593-6.</li>
        <li>Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al; BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014;167(3):304-26.</li>
        <li>De Moerloose P, Schved JF, Nugent D. Rare coagulation disorders: fibrinogen, factor VII and factor XIII. Haemophilia 2016;22(Suppl 5):61-5.</li>
        <li>Peyvandi F, Haertel S, Knaub S, Mannucci PM. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost 2006;4(7):1634-7.</li>
        <li>Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost 2013;39(6):596-606.</li>
        <li>Todd T, Perry DJ. A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies. Haemophilia 2010;16(4):569-83.</li>
        <li>Franchini M, Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Haemost 2010;36:485-92.</li>
        <li>Brown DL, Kouides PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008;14(6):1176-82.</li>
        <li>Emsley J, McEwan PA, Gailani D. Structure and function of factor XI. Blood 2010;115(13):2569-77.</li>
        <li>Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemost 2013;39(6):621-31.</li>
        <li>Rea CJ, Foley JH, Okaisabor O, Sørensen B. FXIII: mechanisms of action in the treatment of hemophilia A. J Thromb Haemost 2014;12(2):159-68.</li>
        <li>Inbal A, Oldenburg J, Carcao M, Rosholm A, Tehranchi R, Nugent D. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood 2012;119:5111-7.</li>
        <li>Lunghi B, Redaelli R, Caimi TM, Corno AR, Bernardi F, Marchetti G. Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin Kdependent coagulation factors. Haemophilia 2011;17(5):822-4.</li>
    </ol>